Although promising preclinical results highlight improved tumor control and antitumor responses, challenges related to safety, biodistribution, and clinical translation remain, challenges related to safety, biodistribution, and clinical translation remain are discussed.
Emilie Lambert, Christophe Nguyen, Sean E. Dunn et al.· Advancement of science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.